or a biological product is licensed under section 351 of the Public Health Service Act, the Director of the Center, may??? (A)require that the holder of an approved application or license conduct 1 or more studies to determine the safety or effectiveness of such drug or biological product, including such safety and effectiveness as compared to other drugs or biological products, to be completed by